Huons, Daewon, and Boryeong did dramatic operation and had lots of expenses on distribution and management

Three domestic pharmaceutical companies are being competitive for the development generic lung cancer drug.

On 29th according to MFDS, there are three generic developing companies which have passed bioequivalence Test(BE Test) for gefinitib

Gefinitib is a main component of Iressa, and CKD, Ildong and Hanmi have been launched to develop the generics.

Iressa is the lung cancer drug that is dev...